Risk of immune‐related pneumonitis for PD 1/ PD ‐L1 inhibitors: Systematic review and network meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of immune‐related pneumonitis for PD 1/ PD ‐L1 inhibitors: Systematic review and network meta‐analysis

Published:2019-04-05 Issue:5 Volume:8 Page:2664-2674
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Huang Yafang¹^ORCID,Fan Haiyu²,Li Ning³,Du Juan¹

Affiliation:

1. School of General Practice and Continuing Education Capital Medical University Beijing China

2. Center of Stroke Beijing Institute for Brain DisordersCapital Medical University Beijing China

3. Department of Library Capital Medical University Beijing China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2104

Reference26 articles.

1. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

2. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

3. Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial

4. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

5. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials;PLOS ONE;2024-04-29

2. Bootstrap-quantile ridge estimator for linear regression with applications;PLOS ONE;2024-04-29

3. Immune-related adverse events associated with first-line immune checkpoint inhibitors for metastatic renal cell carcinoma: A systematic review and network meta-analysis;International Immunopharmacology;2024-04

4. Comparative safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis;European Archives of Oto-Rhino-Laryngology;2024-02-15

5. Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis;Frontiers in Immunology;2023-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3